scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41434-018-0045-4 |
P698 | PubMed publication ID | 30287867 |
P50 | author | You Yu | Q88012386 |
Yixuan Wang | Q88927805 | ||
P2093 | author name string | Shijun Hu | |
Jingjing Li | |||
Wei Lei | |||
Zhen-Ao Zhao | |||
Nianguo Dong | |||
Zhenya Shen | |||
Hongchun Wu | |||
Junwei Liu | |||
Kaili Hao | |||
Xinglong Han | |||
P2860 | cites work | Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease | Q26999363 |
Genome regulation by long noncoding RNAs. | Q27691812 | ||
Blinded by the Light: The Growing Complexity of p53 | Q29547590 | ||
Epigenetic regulation by long noncoding RNAs | Q29618108 | ||
Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs | Q34082965 | ||
Chemically defined generation of human cardiomyocytes | Q34216549 | ||
A long noncoding RNA protects the heart from pathological hypertrophy | Q34287928 | ||
Long noncoding RNAs in patients with acute myocardial infarction | Q34429560 | ||
Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs | Q35059513 | ||
Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. | Q35646709 | ||
Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease | Q35651402 | ||
Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization | Q36245243 | ||
Braveheart, a long noncoding RNA required for cardiovascular lineage commitment | Q36585810 | ||
RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts | Q36855920 | ||
Systematic Characterization of Long Noncoding RNAs Reveals the Contrasting Coordination of Cis- and Trans-Molecular Regulation in Human Fetal and Adult Hearts. | Q36888921 | ||
A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells | Q36924316 | ||
Gene therapy for the treatment of heart failure: promise postponed | Q36953151 | ||
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy | Q37317831 | ||
Long noncoding RNAs in cardiac development and ageing | Q38412337 | ||
Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets? | Q38769281 | ||
MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA-DNA triplex structures. | Q38849879 | ||
Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression | Q38990786 | ||
Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy | Q39002147 | ||
Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure | Q39223911 | ||
Decoding the Long Noncoding RNA During Cardiac Maturation: A Roadmap for Functional Discovery | Q39426172 | ||
FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. | Q39618319 | ||
Long noncoding RNA Chast promotes cardiac remodeling | Q39989173 | ||
Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts. | Q40392730 | ||
Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth | Q42455305 | ||
Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy. | Q42676582 | ||
CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. | Q50044853 | ||
Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction. | Q50935680 | ||
Long Noncoding RNA Meg3 Controls Endothelial Cell Aging and Function: Implications for Regenerative Angiogenesis. | Q54771075 | ||
The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489 | Q87336307 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 511-523 | |
P577 | publication date | 2018-10-04 | |
P1433 | published in | Gene Therapy | Q15763095 |
P1476 | title | Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction | |
P478 | volume | 25 |
Q92621430 | Changes in long non-coding RNA transcriptomic profiles after ischemia-reperfusion injury in rat spinal cord |
Q93270635 | Gene therapy for cardiovascular diseases in China: basic research |
Q98943881 | LDNFSGB: prediction of long non-coding rna and disease association using network feature similarity and gradient boosting |
Q92457942 | Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21 |
Q96124493 | LncRNA KCNQ1OT1 contributes to cardiomyocyte apoptosis by targeting FUS in heart failure |
Q99557258 | LncRNA MM2P-induced, exosome-mediated transfer of Sox9 from monocyte-derived cells modulates primary chondrocytes |
Q64077292 | Long Non-Coding RNA in Vascular Disease and Aging |
Q61807164 | Long Non-coding RNAs: At the Heart of Cardiac Dysfunction? |
Q64964785 | Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition. |
Q92455231 | Long noncoding RNA in cardiac aging and disease |
Q89967543 | Non-coding RNAs Shaping Muscle |
Q96292732 | Type 2 innate lymphoid cells regulation by regulatory T cells attenuates atherosclerosis |
Search more.